Evidence map›Paper›PMID 35057058›Full record

ArticlePharmaceutics2022

Superparamagnetic Iron Oxide Nanoparticles Decorated Mesoporous Silica Nanosystem for Combined Antibiofilm Therapy.

Elena Álvarez, Manuel Estévez, Alvaro Gallo-Cordova, Blanca González, Rafael R Castillo, María Del Puerto Morales, Montserrat Colilla, Isabel Izquierdo-Barba, María Vallet-Regí

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Organically Modified Mesoporous Silica Nanoparticles against Bacterial Resistance.Chemistry of materials : a publication of the American Chemical Society · 2023
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elena ÁlvarezDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.
Manuel EstévezDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.ORCID 0000-0001-7082-824X
Alvaro Gallo-CordovaInstituto de Ciencia de Materiales de Madrid, ICMM/CSIC, Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID 0000-0001-5140-9162
Blanca GonzálezDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.ORCID 0000-0002-0493-6071
Rafael R CastilloDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.ORCID 0000-0003-1957-3098
María Del Puerto MoralesInstituto de Ciencia de Materiales de Madrid, ICMM/CSIC, Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.
Montserrat ColillaDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.ORCID 0000-0003-1961-4160
Isabel Izquierdo-BarbaDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.ORCID 0000-0002-4139-4646
María Vallet-RegíDepartamento de Química en Ciencias Farmacéuticas, Faculdad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain.ORCID 0000-0002-6104-4889
Universidad Complutense de Madrid · ESInstituto de Ciencia de Materiales de Madrid · ES

Funding

European Research Council 694160European Union's Horizon 2020 814410Ministerio de Ciencia e Innovación PID2020-117091RB-I00
6 · The paper itself

Abstract

A crucial challenge to face in the treatment of biofilm-associated infection is the ability of bacteria to develop resistance to traditional antimicrobial therapies based on the administration of antibiotics alone. This study aims to apply magnetic hyperthermia together with controlled antibiotic delivery from a unique magnetic-responsive nanocarrier for a combination therapy against biofilm. The design of the nanosystem is based on antibiotic-loaded mesoporous silica nanoparticles (MSNs) externally functionalized with a thermo-responsive polymer capping layer, and decorated in the outermost surface with superparamagnetic iron oxide nanoparticles (SPIONs). The SPIONs are able to generate heat upon application of an alternating magnetic field (AMF), reaching the temperature needed to induce a change in the polymer conformation from linear to globular, therefore triggering pore uncapping and the antibiotic cargo release. The microbiological assays indicated that exposure of

Indexed as

antibiotic deliverybacterial biofilmcombined therapymesoporous silica nanoparticlessuperparamagnetic iron oxide nanoparticlesthermo-responsive polymer coating

Identifiers

PMID35057058
PMCPMC8778149
OpenAlexW4205570752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.